Article
Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
15 Nov 2022
Abstract excerpt
Broadly neutralizing ability is critical for developing the next-generation SARS-CoV-2 vaccine. We collected sera samples between December 2021-January 2022 from 113 Taiwan naïve participants after their second dose of homologous vaccine (AZD1222, mRNA-1273, BNT162-b2, and MVC-COV1901) and compared the differences in serological responses of various SARS-CoV-2 vaccines. Compared to AZD1222, the two mRNA vaccines...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
